Alan Go to Primary Prevention
This is a "connection" page, showing publications Alan Go has written about Primary Prevention.
Connection Strength
2.006
-
Long-term Outcomes Associated With Implantable Cardioverter Defibrillator in Adults With Chronic Kidney Disease. JAMA Intern Med. 2018 03 01; 178(3):390-398.
Score: 0.602
-
Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators. Heart. 2017 04; 103(7):529-537.
Score: 0.547
-
Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators. J Am Heart Assoc. 2017 Nov 09; 6(11).
Score: 0.147
-
Use of Statins in Adults Older Than 75 Years-Reply. JAMA. 2017 03 14; 317(10):1081.
Score: 0.141
-
Statins for Primary Prevention in Older Adults: Uncertainty and the Need for More Evidence. JAMA. 2016 Nov 15; 316(19):1971-1972.
Score: 0.138
-
Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
Score: 0.133
-
Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA. 2013 May 15; 309(19):2025-34.
Score: 0.108
-
Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice. Circ Cardiovasc Qual Outcomes. 2012 Nov; 5(6):e78-85.
Score: 0.104
-
Rethinking the epidemiology of acute myocardial infarction: challenges and opportunities. Arch Intern Med. 2010 May 10; 170(9):759-64.
Score: 0.088